cFluor® R668 Anti-Human CD38 (HIT2)
View Cart or Continue shopping.
The HIT2 monoclonal antibody binds to human CD38, a 45-kDa type II single-chain transmembrane glycoprotein. CD38, also known as T10, is expressed in high levels on plasma cells, activated T cells and terminally differentiated B cells. CD38 has two functions: a receptor or an enzyme. As a receptor, CD38 binds CD31. As an ectoenzyme, CD38 functions both as ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase to catalyze the synthesis of cyclic ADP-ribose to regulate intracellular calcium level, thus playing an essential role in cell signaling and growth(1)(2). The antibody was conjugated to a fluorophore and puriﬁed by afﬁnity chromatography.
Reactivity: Human, Chimpanzee, Horse
Format: cFluor® R668*
Isotype: Mouse IgG1, κ
Tested Dilution: 5 μL / test
Application: Flow Cytometry
Storage: 2-8°C and protected from Light. Do not freeze
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% BSA (Origin USA)
Each lot of this antibody is quality control tested using flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µL per 1 million cells in a staining volume of 100 µL. If whole blood is analyzed, then use 5 µL per 100 µL. It is recommended that users titrate the antibody to obtain the optimal result for their specific application.
- Lee, Hon Cheung. 2006. Molecular medicine. 317-23
- Deng QW, et al. 2019. J Biol Chem. 18;294(42):15293-15303
These products are for research use only. Not intended for use in diagnostic procedures.
*cFluor® R668 is equivalent to CF®647 manufactured and provided by Biotium, Inc. under an Agreement between Biotium and Cytek (LICENSEE). The manufacture, use, sale, offer for sale, or import of the product is covered by one or more of the patents or pending applications owned or licensed by Biotium. The purchase of this product includes a limited, non-transferable immunity from suit under the foregoing patent claims for using only this amount of product for the purchaser’s own internal research. No right under any other patent claim, no right to perform any patented method, and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser's activities for a fee or other commercial consideration, is conveyed expressly, by implication, or by estoppel.